Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
274
Phase 3 Programs
178
Upcoming Catalysts
12
Next Catalyst
Mar 1, 2026
5wStock performance and market intelligence
15 upcoming, 0 past
For metastatic breast cancer. NDA filing. Extracted from SEC filing: 6-K
SourceFor Hemophilia A. BLA filing. Extracted from SEC filing: 6-K
SourceFor cold agglutinin disease. BLA filing. Extracted from SEC filing: 6-K
SourcePrimary completion for Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1 trial (NCT06744205) in Influenza
SourcePrimary completion for Topical corticosteroids trial (NCT06241118) in Dermatitis Atopic
SourcePrimary completion for Amlitelimab trial (NCT06241118) in Dermatitis Atopic
SourceFor hemophilia. BLA filing. Extracted from SEC filing: 6-K
SourceFor Hemophilia A. BLA filing. Extracted from SEC filing: 6-K
SourcePrimary completion for Amlitelimab trial (NCT06407934) in Dermatitis Atopic
SourceFor Diabetes. NDA filing. Extracted from SEC filing: 6-K
SourcePrimary completion for Belumosudil trial (NCT06082037) in Lung Transplant Rejection
SourcePrimary completion for Itepekimab (SAR440340) trial (NCT06834347) in Chronic Rhinosinusitis With Nasal Polyps
SourcePrimary completion for Investigational hMPV/RSV vaccine trial (NCT06686654) in Human Metapneumovirus Immunization
SourceMachine learning insights and smart money movement
Pending NDA/BLA submissions with predicted PDUFA dates
Clinical development programs and drug candidates
Duvakitug
Crohn's Disease
Semuloparin sodium
Venous Thromboembolism
Sulfonylurea
Diabetes Mellitus, Type 2
Insulin glargine/Lixisenatide (HOE901/AVE0010)
Type 2 Diabetes Mellitus
Aflibercept
Colorectal Cancer Metastatic
hydroxychloroquine
Rheumatoid Arthritis
SR58611A
Anxiety Disorders
Quadrivalent Influenza Vaccine (split virion, inactivated)
Influenza
Amlitelimab
Coeliac Disease
Topical corticosteroids
Dermatitis Atopic
CABAZITAXEL
Prostate Cancer Metastatic
Teriflunomide
Relapsing Multiple Sclerosis
amibegron (SR58611A)
Major Depressive Disorders
Sarilumab
Rheumatoid Arthritis
GLIMEPIRIDE
Diabetes Mellitus, Type 2
Artesunate + Amodiaquine
Malaria
paracetamol 4.8% paediatric oral suspension
Fever
DTaP-HB PRP~T Combined Vaccine
Diphtheria
leflunomide
Arthritis, Rheumatoid
alfuzosin (SL770499)
Urinary Bladder Neurogenic
Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)
Hygiene
Meningococcal Polysaccharide Diphtheria Toxoid Conjugate
Meningitis
lixisenatide AVE0010
Type 2 Diabetes Mellitus
DOCETAXEL(XRP6976) + MODAFINIL
Prostatic Neoplasms
Allopurinol
Tumor Lysis Syndrome
Teriflunomide (HMR1726)
Multiple Sclerosis
Dupilumab SAR231893
Chronic Rhinosinusitis Without Nasal Polyps
Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine
Meningococcal Immunization
Insulin human/Insuman Comb 25 (HR1799)
Type 2 Diabetes Mellitus
Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine MenACYW conjugate vaccine
Healthy Volunteers (Meningococcal Infection)
Yellow fever vaccine (live)
Yellow Fever
SR123781A
Venous Thromboembolism
Rilzabrutinib
Sickle Cell Disease
Irinotecan
Colorectal Cancer Metastatic
clopidogrel (SR25990)
Arteriosclerosis
enoxaparin
Abdominal Neoplasms
ombrabulin (AVE8062)
Non-small Cell Lung Cancer
Lactic acid
Hygiene
Lantus (insulin glargine [rDNA origin] injection)
Diabetes Mellitus
Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower
Hygiene
Docetaxel/DDP
Lung Neoplasms
Thiocolchicoside+Ketoprofen
Low Back Pain
Insulin glargine U300 (new formulation of insulin glargine) HOE901
Diabetes Mellitus Type 2
FluBlok®
Influenza
ALIROCUMAB SAR236553 (REGN727)
Hypercholesterolemia
Insulin glargine new formulation (HOE901)
Type 1 Diabetes Mellitus
Quadrivalent Influenza Vaccine
Influenza
DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus)
Pertussis Immunisation
Japanese encephalitis vaccine
Japanese Encephalitis
Caplacizumab (ALX-0081)
Thrombotic Thrombocytopenic Purpura
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine
Healthy Volunteers (Meningococcal Infection)
Pneumo 23
Streptococcus Pneumoniae
Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine
Meningococcal Immunisation
Lactic acid (Dermacid)
Healthy
Insuline glulisine
Diabetes Mellitus, Type 1
Oxaliplatin
Stomach Neoplasms
riliprubart
Chronic Inflammatory Demyelinating Polyneuropathy
dianicline
Smoking
Isatuximab
Relapsed/Refractory Multiple Myeloma
FDC KETOPROFEN+OMEPRAZOLE
Pain
Clotting factor concentrates (CFC) or bypassing agents (BPA)
Hemophilia
Live, attenuated, dengue serotype 1, 2, 3, 4 virus
Dengue Fever
Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®
Diphtheria
ALFUZOSIN
Benign Prostatic Hyperplasia
larotaxel (XRP9881)
Breast Neoplasms
DAPTACEL®. (DTaP), IPOL®., and ActHIB®.
Diphtheria
Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine
Neisseria Meningitidis
PCV21 vaccine
Pneumococcal Immunization
Cisplatin
Nasopharyngeal Neoplasms
Ramipril
Glomerulonephritis
ZD6474 (Vandetanib)
Thyroid Cancer
SAR342434
Type 1 Diabetes Mellitus
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate Vaccine)
Meningococcal Immunisation (Healthy Volunteers)
Oxaliplatin (SR96669)
Gastric Cancer
Triamcinolone
Rhinitis, Allergic, Perennial
Glycerine Vegetal Soap Granado Traditional
Hygiene
sevelamer carbonate 800mg
Renal Failure Chronic
Capecitabine
Pancreatic Neoplasms
Asthma Controller Therapies
Asthma
Thyrogen (thyrotropin alfa for injection)
Differentiated Thyroid Cancer
Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid)
Hygiene
docetaxel (XRP6976)
Therapy, Prostatic Neoplasms
Quadrivalent Recombinant Influenza Vaccine (RIV4)
Influenza (Healthy Volunteers)
Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine
Diphtheria
SGLT2 inhibitor
Type 2 Diabetes Mellitus
DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)
Diphtheria
Erlotinib
Non Small Cell Lung Cancer
Quadrivalent influenza vaccine (QIV) (split virion, inactivated) Northern Hemisphere (NH) 2015-2016
Influenza
insulin secretagogue
Diabetes Mellitus, Type 2
5-FLUOROURACIL
Head and Neck Neoplasms
hydroxychloroquine (Z0188)
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib
Diphtheria
Belumosudil
Lung Transplant Rejection
fexofenadine/Allegra (M016455)
Rhinitis Perennial
ciclesonide (XRP1526)
Respiratory Tract Diseases
Clopidogrel
Arterial Occlusive Diseases
Dermacyd PH_DETINLYN (Lactic Acid)
Hygiene
Myozyme
Pompe Disease (Late-onset)
Lipid-Modifying Therapy (LMT)
Hypercholesterolemia
efanesoctocog alfa (BIVV001)
Hemophilia A
LACTIC ACID(ND)
Hygiene
rasburicase (SR29142)
Nutritional and Metabolic Diseases
Enoxaparin sodium
Arthroplasty, Replacement, Hip
Insulin Glargine
Diabetes Mellitus, Type 2
Lunsekimig
Chronic Obstructive Pulmonary Disease
SR121463B
Inappropriate ADH Syndrome
DTaP-IPV-HB-PRP~T vaccine
Diphtheria
Alirocumab
Hypercholesterolemia
vandetanib
Lung Cancer
Sevelamer carbonate (Renvela®)
Chronic Kidney Disease
Venglustat (GZ402671)
Fabry Disease
Eliglustat tartrate
Gaucher Disease, Type 1
Influenza virus vaccine (split virion, inactivated)
Influenza
sarilumab SAR153191 (REGN88)
Rheumatoid Arthritis
Lipid Modifying Therapy (LMT)
Hypercholesterolaemia
Lixisenatide (AVE0010)
Type 2 Diabetes
escitalopram
Major Depressive Disorder
rimonabant (SR141716)
Maintenance of Smoking Cessation
Doxorubicin
Breast Neoplasms
Telithromycin (HMR3647)
Otitis Media
Saredutant
Anxiety
Tolevamer potassium-sodium (GT267-004)
Clostridium Enterocolitis
Rimonabant
Metabolic Syndrome
Fitusiran
Hemophilia
isatuximab SAR650984
Plasma Cell Myeloma
Glimepiride (HOE490)
Type 2 Diabetes Mellitus
Gemcitabine
Nasopharyngeal Neoplasms
alemtuzumab
Multiple Sclerosis, Relapsing-Remitting
Insulin glargine/lixisenatide Fixed Ratio Combination
Type 2 Diabetes
Dermacyd PH_DETINBACK (Lactic Acid)
Hygiene
Interferon β-1a
Multiple Sclerosis
EMLA Cream
Facial Wrinkles at the Nasolabial Folds
MenACYW conjugate vaccine
Meningitis, Meningococcal
Phosphatidylcholine
Hepatic and Hepatobiliary Disorders
Fexofenadine
Asthma
Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative
Influenza
Metformin
Type 2 Diabetes Mellitus
Dupilumab
Asthma
Inhaled Corticosteroid
Chronic Obstructive Pulmonary Disease
Lactic Acid (Dermacyd PH_DETINLYN Tangerine Mix)
Hygiene
Eliglustat, GZ385660
Gaucher Disease
insulin glulisine / insulin glargine
Diabetes Mellitus, Type 1
Insulin Therapy
Diabetes Mellitus, Type 2
factor concentrates
Hemophilia A
Vaxneuvance vaccine
Pneumococcal Immunization
xaliproden (SR57746A)
Alzheimer Disease
SR34006 (idraparinux sodium) Injection
Atrial Fibrillation
risedronate
Osteoporosis
Bypassing agents
Hemophilia A
Insulin glargine (U300)
Type 2 Diabetes Mellitus
Insulin Glulisine
Diabetes Mellitus
Moisturizers
Neurodermatitis
SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent D614) (primary series)
COVID-19
amiodarone
Atrial Fibrillation
Docetaxel
Prostatic Neoplasms
Open-label Semuloparin sodium
Venous Thromboembolism
dronedarone (SR33589)
Atrial Fibrillation
Adalimumab
Rheumatoid Arthritis
Itepekimab (SAR440340)
Chronic Rhinosinusitis With Nasal Polyps
Doxorubicine + docetaxel sequential
Breast Neoplasms
ChimeriVax™-JE
Japanese Encephalitis
Olipudase alfa
Sphingomyelin Lipidosis
Prednisone or Prednisolone
Prostatic Neoplasms
Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®)
Carcinoma
SENNA+CASSIA(Naturetti)
Constipation
Pomalidomide
Plasma Cell Myeloma
Tolebrutinib
Relapsing Multiple Sclerosis
Fabrazyme (agalsidase beta)
Fabry Disease
Meningococcal polysaccharide group A, C, W-135 and Y Conjugate vaccine
Meningococcal Immunisation (Healthy Volunteers)
Sevelamer Hydrochloride (Renagel®)
Peritoneal Dialysis
Antihyperglycemic Drug
Hypercholesterolaemia
Glutamine
Colorectal Neoplasms
FluCAM [Fludara + Campath]
B-Cell Chronic Lymphocytic Leukemia
lactoserum
Hygiene
Caplacizumab
Acquired Thrombotic Thrombocytopenic Purpura
Riluzole
Huntington Disease
Saredutant succinate (SR48968C)
Depressive Disorder
clopidogrel (SR25990C)
Atrial Fibrillation
Influenza Virus Vaccine USP Trivalent Types A and B
Influenza
Monovalent Subvirion A/H1N1 Influenza vaccine
Influenza
Artefenomel (OZ439)
Plasmodium Falciparum Infection
SAR441566
Rheumatoid Arthritis
Polysaccharide Diphtheria Toxoid Conjugate Vaccine
Meningococcal Meningitis
SSR150106
Rheumatoid Arthritis
A/H5N1 inactivated, split-virion influenza virus
Influenza
SAR445088 (IV)
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1
Influenza
A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine
Influenza
anti-thymocyte globulin
Myelodysplastic Syndromes
Long term follow up in all patients who received SAR422459 in previous study TDU13583
Stargardt's Disease
SR57667B
Alzheimer Disease
SAR444200
Neoplasm
ataciguat (HMR1766)
Pain
SAR161271
Type 1 Diabetes Mellitus
docetaxel and carboplatin
Lung Neoplasms
SSR149415
Depressive Disorder
Pneumococcal Conjugate Vaccine formulation 1
Pneumococcal Immunisation
Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine
Meningitis
Brivekimig
Hidradenitis Suppurativa
Panblok + MF59 Dose 1
Influenza
AVE5530
Hypercholesterolemia
SAR3419
Diffuse Large B-Cell Lymphoma
Inactivated Poliomyelitis vaccine (IMOVAX)
Poliomyelitis
sevelamer carbonate, sevelamer hydrochloride
Chronic Kidney Disease
HOE140 Icatibant
Joint Disease
Meningococcal Polysaccharide Diphtheria Protein Conjugate (Menactra®)
Meningitis
Swine A/H1N1 influenza vaccine (split virion, inactivated)
Influenza
Inactivated, split-virion influenza vaccine
Orthomyxoviridae Infection
G-CSF Plus Plerixafor
Multiple Myeloma
ALX-0061
Rheumatoid Arthritis
clofarabine
Acute Myelogenous Leukemia
SAR443122
Cutaneous Lupus Erythematosus
Alglucosidase alfa
Glycogen Storage Disease Type II
ATN-103
Active Rheumatoid Arthritis
Avalglucosidase Alfa
Glycogen Storage Disease Type II Pompe Disease
CYD Dengue Vaccine (5-dose formulation)
Dengue Fever
ChimeriVax-WN02 Low Dose
West Nile Fever
CYD Dengue Vaccine
Dengue Fever
Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)
Influenza
Deferitrin (GT56-252)
Beta-Thalassemia
AVE2268
Type 2 Diabetes Mellitus
SAR441344 IV
Multiple Sclerosis
VRVg 2
Rabies Virus
XL147 (SAR245408)
Breast Cancer
Polysaccharide Diphtheria Conjugate Vaccine
Meningitis
THOR-707
Oesophageal Squamous Cell Carcinoma
docetaxel and cisplatin followed by concurrent chemoradiotherapy with docetaxel and cisplatin + radiotherapy
Lung Neoplasms
Blood draw for the laboratory assessment
Usher's Syndrome
Fludarabine Phosphate (Fludara)
Non Hodgkin Lymphoma
SAR442970
Hidradenitis Suppurativa
Thymoglobulin [Anti-thymocyte Globulin (rabbit)]
Cadaveric Donor Renal Transplantation
Genz-644470
Kidney Failure, Chronic
statins
Hypercholesterolaemia
Atorvastatin
Hypercholesterolemia
docetaxel and cisplatin
Head and Neck Neoplasms
Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA)
Influenza
Hexadecasaccharide (SR123781A)
Coronary Atherosclerosis
VASOPRESSIN V1B RECEPTOR ANTAGONIST (SSR149415)
Major Depressive Disorder
Bicalutamide
Prostate Cancer
Otamixaban (XRP0673)
Angioplasty, Transluminal, Percutaneous Coronary
SAR442168
Relapsing Multiple Sclerosis
Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV
Pertussis
AVE1625 B
Obesity
Investigational hMPV/RSV vaccine
Human Metapneumovirus Immunization
SAR156597
Idiopathic Pulmonary Fibrosis
Cabazitaxel (XRP6258)
Malignant Solid Tumor - Malignant Nervous System Neoplasm
ILX651
Hormone-refractory Prostate Cancer
XRP0038 (NV1FGF)
Severe Peripheral Artery Occlusive Disease
clofarabine (IV formulation)
Acute Myelogenous Leukemia
Interferon-β
Multiple Sclerosis
BIVV020 (SAR445088)
Transplant Rejection
CoV2 preS dTM-AF03 (low-dose)
COVID-19 (Healthy Volunteers)
Menomune®: A, C, Y, W 135 Meningococcal Polysaccharide
Meningitis
Acne mRNA vaccine
Acne
aminopterin
Leukemia
Teplizumab
Type 1 Diabetes Mellitus
Aldurazyme (Recombinant Human Alpha-L-Iduronidase)
Mucopolysaccharidosis I
Purified Vero Rabies Vaccine - Serum Free
Rabies
plerixafor
Ewing's Sarcoma/Soft Tissue Sarcoma
Avalglucosidase alfa (GZ402666)
Glycogen Storage Disease Type II-Pompe's Disease
RSV vaccine candiate formulation 1
Respiratory Syncytial Virus Immunization
SAR110894
Dementia Alzheimer's Type
Oxaliplatin, capecitabine, radiotherapy
Rectal Neoplasms
ZD6474
Carcinoma, Non-Small-Cell Lung
Tetravalent CYD Dengue Vaccine , 5555 formulation
Dengue Fever
satavaptan (SR121463B)
Ascites
MenABCYW conjugate vaccine
Meningococcal Immunisation
S-1
Gastric Cancer
Clostridium difficile toxoids A and B (Low-dose with adjuvant)
Clostridium Difficile Infection
Any Inhaled Corticosteroids as prescribed by treating physician as standard of care
Chronic Obstructive Pulmonary Disease
SAR445088 (BIVV020)
Immune Thrombocytopenia (ITP)
Quadrivalent Influenza mRNA Vaccine MRT5410
Influenza Immunization
Influenza virus vaccine (2004-2005 Formulation)
Influenza
Split virion, inactivated Influenza vaccine
Influenza
| Drug Name | Phase | Indication | Designations |
|---|---|---|---|
Duvakitug | Phase 3 | Crohn's Disease | - |
Semuloparin sodium | Phase 3 | Venous Thromboembolism | - |
Sulfonylurea | Phase 3 | Diabetes Mellitus, Type 2 | - |
Insulin glargine/Lixisenatide (HOE901/AVE0010) | Phase 3 | Type 2 Diabetes Mellitus | - |
Aflibercept | Phase 3 | Colorectal Cancer Metastatic | - |
hydroxychloroquine | Phase 3 | Rheumatoid Arthritis | - |
SR58611A | Phase 3 | Anxiety Disorders | - |
Quadrivalent Influenza Vaccine (split virion, inactivated) | Phase 3 | Influenza | - |
Amlitelimab | Phase 3 | Coeliac Disease | - |
Topical corticosteroids | Phase 3 | Dermatitis Atopic | - |
CABAZITAXEL | Phase 3 | Prostate Cancer Metastatic | - |
Teriflunomide | Phase 3 | Relapsing Multiple Sclerosis | - |
amibegron (SR58611A) | Phase 3 | Major Depressive Disorders | - |
Sarilumab | Phase 3 | Rheumatoid Arthritis | - |
GLIMEPIRIDE | Phase 3 | Diabetes Mellitus, Type 2 | - |
Artesunate + Amodiaquine | Phase 3 | Malaria | - |
paracetamol 4.8% paediatric oral suspension | Phase 3 | Fever | - |
DTaP-HB PRP~T Combined Vaccine | Phase 3 | Diphtheria | - |
leflunomide | Phase 3 | Arthritis, Rheumatoid | - |
alfuzosin (SL770499) | Phase 3 | Urinary Bladder Neurogenic | - |
Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix) | Phase 3 | Hygiene | - |
Meningococcal Polysaccharide Diphtheria Toxoid Conjugate | Phase 3 | Meningitis | - |
lixisenatide AVE0010 | Phase 3 | Type 2 Diabetes Mellitus | - |
DOCETAXEL(XRP6976) + MODAFINIL | Phase 3 | Prostatic Neoplasms | - |
Allopurinol | Phase 3 | Tumor Lysis Syndrome | - |
Teriflunomide (HMR1726) | Phase 3 | Multiple Sclerosis | - |
Dupilumab SAR231893 | Phase 3 | Chronic Rhinosinusitis Without Nasal Polyps | - |
Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine | Phase 3 | Meningococcal Immunization | - |
Insulin human/Insuman Comb 25 (HR1799) | Phase 3 | Type 2 Diabetes Mellitus | - |
Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine MenACYW conjugate vaccine | Phase 3 | Healthy Volunteers (Meningococcal Infection) | - |
Yellow fever vaccine (live) | Phase 3 | Yellow Fever | - |
SR123781A | Phase 3 | Venous Thromboembolism | - |
Rilzabrutinib | Phase 3 | Sickle Cell Disease | - |
Irinotecan | Phase 3 | Colorectal Cancer Metastatic | - |
clopidogrel (SR25990) | Phase 3 | Arteriosclerosis | - |
enoxaparin | Phase 3 | Abdominal Neoplasms | - |
ombrabulin (AVE8062) | Phase 3 | Non-small Cell Lung Cancer | - |
Lactic acid | Phase 3 | Hygiene | - |
Lantus (insulin glargine [rDNA origin] injection) | Phase 3 | Diabetes Mellitus | - |
Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower | Phase 3 | Hygiene | - |
Docetaxel/DDP | Phase 3 | Lung Neoplasms | - |
Thiocolchicoside+Ketoprofen | Phase 3 | Low Back Pain | - |
Insulin glargine U300 (new formulation of insulin glargine) HOE901 | Phase 3 | Diabetes Mellitus Type 2 | - |
FluBlok® | Phase 3 | Influenza | - |
ALIROCUMAB SAR236553 (REGN727) | Phase 3 | Hypercholesterolemia | - |
Insulin glargine new formulation (HOE901) | Phase 3 | Type 1 Diabetes Mellitus | - |
Quadrivalent Influenza Vaccine | Phase 3 | Influenza | - |
DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus) | Phase 3 | Pertussis Immunisation | - |
Japanese encephalitis vaccine | Phase 3 | Japanese Encephalitis | - |
Caplacizumab (ALX-0081) | Phase 3 | Thrombotic Thrombocytopenic Purpura | - |
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine | Phase 3 | Healthy Volunteers (Meningococcal Infection) | - |
Pneumo 23 | Phase 3 | Streptococcus Pneumoniae | - |
Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine | Phase 3 | Meningococcal Immunisation | - |
Lactic acid (Dermacid) | Phase 3 | Healthy | - |
Insuline glulisine | Phase 3 | Diabetes Mellitus, Type 1 | - |
Oxaliplatin | Phase 3 | Stomach Neoplasms | - |
riliprubart | Phase 3 | Chronic Inflammatory Demyelinating Polyneuropathy | - |
dianicline | Phase 3 | Smoking | - |
Isatuximab | Phase 3 | Relapsed/Refractory Multiple Myeloma | - |
FDC KETOPROFEN+OMEPRAZOLE | Phase 3 | Pain | - |
Clotting factor concentrates (CFC) or bypassing agents (BPA) | Phase 3 | Hemophilia | - |
Live, attenuated, dengue serotype 1, 2, 3, 4 virus | Phase 3 | Dengue Fever | - |
Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar® | Phase 3 | Diphtheria | - |
ALFUZOSIN | Phase 3 | Benign Prostatic Hyperplasia | - |
larotaxel (XRP9881) | Phase 3 | Breast Neoplasms | - |
DAPTACEL®. (DTaP), IPOL®., and ActHIB®. | Phase 3 | Diphtheria | - |
Menactra®: Meningococcal A, C, Y, and W 135 Polysaccharide Diphtheria Toxoid Conjugate vaccine | Phase 3 | Neisseria Meningitidis | - |
PCV21 vaccine | Phase 3 | Pneumococcal Immunization | - |
Cisplatin | Phase 3 | Nasopharyngeal Neoplasms | - |
Ramipril | Phase 3 | Glomerulonephritis | - |
ZD6474 (Vandetanib) | Phase 3 | Thyroid Cancer | - |
SAR342434 | Phase 3 | Type 1 Diabetes Mellitus | - |
Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine (MenACYW Conjugate Vaccine) | Phase 3 | Meningococcal Immunisation (Healthy Volunteers) | - |
Oxaliplatin (SR96669) | Phase 3 | Gastric Cancer | - |
Triamcinolone | Phase 3 | Rhinitis, Allergic, Perennial | - |
Glycerine Vegetal Soap Granado Traditional | Phase 3 | Hygiene | - |
sevelamer carbonate 800mg | Phase 3 | Renal Failure Chronic | - |
Capecitabine | Phase 3 | Pancreatic Neoplasms | - |
Asthma Controller Therapies | Phase 3 | Asthma | - |
Thyrogen (thyrotropin alfa for injection) | Phase 3 | Differentiated Thyroid Cancer | - |
Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) | Phase 3 | Hygiene | - |
docetaxel (XRP6976) | Phase 3 | Therapy, Prostatic Neoplasms | - |
Quadrivalent Recombinant Influenza Vaccine (RIV4) | Phase 3 | Influenza (Healthy Volunteers) | - |
Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine | Phase 3 | Diphtheria | - |
SGLT2 inhibitor | Phase 3 | Type 2 Diabetes Mellitus | - |
DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine) | Phase 3 | Diphtheria | - |
Erlotinib | Phase 3 | Non Small Cell Lung Cancer | - |
Quadrivalent influenza vaccine (QIV) (split virion, inactivated) Northern Hemisphere (NH) 2015-2016 | Phase 3 | Influenza | - |
insulin secretagogue | Phase 3 | Diabetes Mellitus, Type 2 | - |
5-FLUOROURACIL | Phase 3 | Head and Neck Neoplasms | - |
hydroxychloroquine (Z0188) | Phase 3 | Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus | - |
Diphtheria, Tetanus, Polio, Acellular Pertussis and Hib | Phase 3 | Diphtheria | - |
Belumosudil | Phase 3 | Lung Transplant Rejection | - |
fexofenadine/Allegra (M016455) | Phase 3 | Rhinitis Perennial | - |
ciclesonide (XRP1526) | Phase 3 | Respiratory Tract Diseases | - |
Clopidogrel | Phase 3 | Arterial Occlusive Diseases | - |
Dermacyd PH_DETINLYN (Lactic Acid) | Phase 3 | Hygiene | - |
Myozyme | Phase 3 | Pompe Disease (Late-onset) | - |
Lipid-Modifying Therapy (LMT) | Phase 3 | Hypercholesterolemia | - |
efanesoctocog alfa (BIVV001) | Phase 3 | Hemophilia A | - |
LACTIC ACID(ND) | Phase 3 | Hygiene | - |
rasburicase (SR29142) | Phase 3 | Nutritional and Metabolic Diseases | - |
Enoxaparin sodium | Phase 3 | Arthroplasty, Replacement, Hip | - |
Insulin Glargine | Phase 3 | Diabetes Mellitus, Type 2 | - |
Lunsekimig | Phase 3 | Chronic Obstructive Pulmonary Disease | - |
SR121463B | Phase 3 | Inappropriate ADH Syndrome | - |
DTaP-IPV-HB-PRP~T vaccine | Phase 3 | Diphtheria | - |
Alirocumab | Phase 3 | Hypercholesterolemia | - |
vandetanib | Phase 3 | Lung Cancer | - |
Sevelamer carbonate (Renvela®) | Phase 3 | Chronic Kidney Disease | - |
Venglustat (GZ402671) | Phase 3 | Fabry Disease | - |
Eliglustat tartrate | Phase 3 | Gaucher Disease, Type 1 | - |
Influenza virus vaccine (split virion, inactivated) | Phase 3 | Influenza | - |
sarilumab SAR153191 (REGN88) | Phase 3 | Rheumatoid Arthritis | - |
Lipid Modifying Therapy (LMT) | Phase 3 | Hypercholesterolaemia | - |
Lixisenatide (AVE0010) | Phase 3 | Type 2 Diabetes | - |
escitalopram | Phase 3 | Major Depressive Disorder | - |
rimonabant (SR141716) | Phase 3 | Maintenance of Smoking Cessation | - |
Doxorubicin | Phase 3 | Breast Neoplasms | - |
Telithromycin (HMR3647) | Phase 3 | Otitis Media | - |
Saredutant | Phase 3 | Anxiety | - |
Tolevamer potassium-sodium (GT267-004) | Phase 3 | Clostridium Enterocolitis | - |
Rimonabant | Phase 3 | Metabolic Syndrome | - |
Fitusiran | Phase 3 | Hemophilia | - |
isatuximab SAR650984 | Phase 3 | Plasma Cell Myeloma | - |
Glimepiride (HOE490) | Phase 3 | Type 2 Diabetes Mellitus | - |
Gemcitabine | Phase 3 | Nasopharyngeal Neoplasms | - |
alemtuzumab | Phase 3 | Multiple Sclerosis, Relapsing-Remitting | - |
Insulin glargine/lixisenatide Fixed Ratio Combination | Phase 3 | Type 2 Diabetes | - |
Dermacyd PH_DETINBACK (Lactic Acid) | Phase 3 | Hygiene | - |
Interferon β-1a | Phase 3 | Multiple Sclerosis | - |
EMLA Cream | Phase 3 | Facial Wrinkles at the Nasolabial Folds | - |
MenACYW conjugate vaccine | Phase 3 | Meningitis, Meningococcal | - |
Phosphatidylcholine | Phase 3 | Hepatic and Hepatobiliary Disorders | - |
Fexofenadine | Phase 3 | Asthma | - |
Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative | Phase 3 | Influenza | - |
Metformin | Phase 3 | Type 2 Diabetes Mellitus | - |
Dupilumab | Phase 3 | Asthma | - |
Inhaled Corticosteroid | Phase 3 | Chronic Obstructive Pulmonary Disease | - |
Lactic Acid (Dermacyd PH_DETINLYN Tangerine Mix) | Phase 3 | Hygiene | - |
Eliglustat, GZ385660 | Phase 3 | Gaucher Disease | - |
insulin glulisine / insulin glargine | Phase 3 | Diabetes Mellitus, Type 1 | - |
Insulin Therapy | Phase 3 | Diabetes Mellitus, Type 2 | - |
factor concentrates | Phase 3 | Hemophilia A | - |
Vaxneuvance vaccine | Phase 3 | Pneumococcal Immunization | - |
xaliproden (SR57746A) | Phase 3 | Alzheimer Disease | - |
SR34006 (idraparinux sodium) Injection | Phase 3 | Atrial Fibrillation | - |
risedronate | Phase 3 | Osteoporosis | - |
Bypassing agents | Phase 3 | Hemophilia A | - |
Insulin glargine (U300) | Phase 3 | Type 2 Diabetes Mellitus | - |
Insulin Glulisine | Phase 3 | Diabetes Mellitus | - |
Moisturizers | Phase 3 | Neurodermatitis | - |
SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent D614) (primary series) | Phase 3 | COVID-19 | - |
amiodarone | Phase 3 | Atrial Fibrillation | - |
Docetaxel | Phase 3 | Prostatic Neoplasms | - |
Open-label Semuloparin sodium | Phase 3 | Venous Thromboembolism | - |
dronedarone (SR33589) | Phase 3 | Atrial Fibrillation | - |
Adalimumab | Phase 3 | Rheumatoid Arthritis | - |
Itepekimab (SAR440340) | Phase 3 | Chronic Rhinosinusitis With Nasal Polyps | - |
Doxorubicine + docetaxel sequential | Phase 3 | Breast Neoplasms | - |
ChimeriVax™-JE | Phase 3 | Japanese Encephalitis | - |
Olipudase alfa | Phase 3 | Sphingomyelin Lipidosis | - |
Prednisone or Prednisolone | Phase 3 | Prostatic Neoplasms | - |
Aflibercept (ziv-aflibercept, AVE0005, VEGF trap, ZALTRAP®) | Phase 3 | Carcinoma | - |
SENNA+CASSIA(Naturetti) | Phase 3 | Constipation | - |
Pomalidomide | Phase 3 | Plasma Cell Myeloma | - |
Tolebrutinib | Phase 3 | Relapsing Multiple Sclerosis | - |
Fabrazyme (agalsidase beta) | Phase 3 | Fabry Disease | - |
Meningococcal polysaccharide group A, C, W-135 and Y Conjugate vaccine | Phase 3 | Meningococcal Immunisation (Healthy Volunteers) | - |
Sevelamer Hydrochloride (Renagel®) | Phase 3 | Peritoneal Dialysis | - |
Antihyperglycemic Drug | Phase 3 | Hypercholesterolaemia | - |
Glutamine | Phase 3 | Colorectal Neoplasms | - |
FluCAM [Fludara + Campath] | Phase 3 | B-Cell Chronic Lymphocytic Leukemia | - |
lactoserum | Phase 3 | Hygiene | - |
Caplacizumab | Phase 3 | Acquired Thrombotic Thrombocytopenic Purpura | - |
Riluzole | Phase 3 | Huntington Disease | - |
Saredutant succinate (SR48968C) | Phase 3 | Depressive Disorder | - |
clopidogrel (SR25990C) | Phase 3 | Atrial Fibrillation | - |
Influenza Virus Vaccine USP Trivalent Types A and B | Phase 2 | Influenza | - |
Monovalent Subvirion A/H1N1 Influenza vaccine | Phase 2 | Influenza | - |
Artefenomel (OZ439) | Phase 2 | Plasmodium Falciparum Infection | - |
SAR441566 | Phase 2 | Rheumatoid Arthritis | - |
Polysaccharide Diphtheria Toxoid Conjugate Vaccine | Phase 2 | Meningococcal Meningitis | - |
SSR150106 | Phase 2 | Rheumatoid Arthritis | - |
A/H5N1 inactivated, split-virion influenza virus | Phase 2 | Influenza | - |
SAR445088 (IV) | Phase 2 | Chronic Inflammatory Demyelinating Polyradiculoneuropathy | - |
Trivalent (TIV) messenger ribonucleic acid (mRNA) hemagglutinin (HA) Vaccine 1 | Phase 2 | Influenza | - |
A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine | Phase 2 | Influenza | - |
anti-thymocyte globulin | Phase 2 | Myelodysplastic Syndromes | - |
Long term follow up in all patients who received SAR422459 in previous study TDU13583 | Phase 2 | Stargardt's Disease | - |
SR57667B | Phase 2 | Alzheimer Disease | - |
SAR444200 | Phase 2 | Neoplasm | - |
ataciguat (HMR1766) | Phase 2 | Pain | - |
SAR161271 | Phase 2 | Type 1 Diabetes Mellitus | - |
docetaxel and carboplatin | Phase 2 | Lung Neoplasms | - |
SSR149415 | Phase 2 | Depressive Disorder | - |
Pneumococcal Conjugate Vaccine formulation 1 | Phase 2 | Pneumococcal Immunisation | - |
Meningococcal Polysaccharide (Serogroups A, C, Y, and W135) Tetanus Toxoid Conjugate Vaccine | Phase 2 | Meningitis | - |
Brivekimig | Phase 2 | Hidradenitis Suppurativa | - |
Panblok + MF59 Dose 1 | Phase 2 | Influenza | - |
AVE5530 | Phase 2 | Hypercholesterolemia | - |
SAR3419 | Phase 2 | Diffuse Large B-Cell Lymphoma | - |
Inactivated Poliomyelitis vaccine (IMOVAX) | Phase 2 | Poliomyelitis | - |
sevelamer carbonate, sevelamer hydrochloride | Phase 2 | Chronic Kidney Disease | - |
HOE140 Icatibant | Phase 2 | Joint Disease | - |
Meningococcal Polysaccharide Diphtheria Protein Conjugate (Menactra®) | Phase 2 | Meningitis | - |
Swine A/H1N1 influenza vaccine (split virion, inactivated) | Phase 2 | Influenza | - |
Inactivated, split-virion influenza vaccine | Phase 2 | Orthomyxoviridae Infection | - |
G-CSF Plus Plerixafor | Phase 2 | Multiple Myeloma | - |
ALX-0061 | Phase 2 | Rheumatoid Arthritis | - |
clofarabine | Phase 2 | Acute Myelogenous Leukemia | - |
SAR443122 | Phase 2 | Cutaneous Lupus Erythematosus | - |
Alglucosidase alfa | Phase 2 | Glycogen Storage Disease Type II | - |
ATN-103 | Phase 2 | Active Rheumatoid Arthritis | - |
Avalglucosidase Alfa | Phase 2 | Glycogen Storage Disease Type II Pompe Disease | - |
CYD Dengue Vaccine (5-dose formulation) | Phase 2 | Dengue Fever | - |
ChimeriVax-WN02 Low Dose | Phase 2 | West Nile Fever | - |
CYD Dengue Vaccine | Phase 2 | Dengue Fever | - |
Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant) | Phase 2 | Influenza | - |
Deferitrin (GT56-252) | Phase 2 | Beta-Thalassemia | - |
AVE2268 | Phase 2 | Type 2 Diabetes Mellitus | - |
SAR441344 IV | Phase 2 | Multiple Sclerosis | - |
VRVg 2 | Phase 2 | Rabies Virus | - |
XL147 (SAR245408) | Phase 2 | Breast Cancer | - |
Polysaccharide Diphtheria Conjugate Vaccine | Phase 2 | Meningitis | - |
THOR-707 | Phase 2 | Oesophageal Squamous Cell Carcinoma | - |
docetaxel and cisplatin followed by concurrent chemoradiotherapy with docetaxel and cisplatin + radiotherapy | Phase 2 | Lung Neoplasms | - |
Blood draw for the laboratory assessment | Phase 2 | Usher's Syndrome | - |
Fludarabine Phosphate (Fludara) | Phase 2 | Non Hodgkin Lymphoma | - |
SAR442970 | Phase 2 | Hidradenitis Suppurativa | - |
Thymoglobulin [Anti-thymocyte Globulin (rabbit)] | Phase 2 | Cadaveric Donor Renal Transplantation | - |
Genz-644470 | Phase 2 | Kidney Failure, Chronic | - |
statins | Phase 2 | Hypercholesterolaemia | - |
Atorvastatin | Phase 2 | Hypercholesterolemia | - |
docetaxel and cisplatin | Phase 2 | Head and Neck Neoplasms | - |
Monovalent Subvirion A/H1N1 Influenza vaccine (7.5 µg of HA) | Phase 2 | Influenza | - |
Hexadecasaccharide (SR123781A) | Phase 2 | Coronary Atherosclerosis | - |
VASOPRESSIN V1B RECEPTOR ANTAGONIST (SSR149415) | Phase 2 | Major Depressive Disorder | - |
Bicalutamide | Phase 2 | Prostate Cancer | - |
Otamixaban (XRP0673) | Phase 2 | Angioplasty, Transluminal, Percutaneous Coronary | - |
SAR442168 | Phase 2 | Relapsing Multiple Sclerosis | - |
Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV | Phase 2 | Pertussis | - |
AVE1625 B | Phase 2 | Obesity | - |
Investigational hMPV/RSV vaccine | Phase 2 | Human Metapneumovirus Immunization | - |
SAR156597 | Phase 2 | Idiopathic Pulmonary Fibrosis | - |
Cabazitaxel (XRP6258) | Phase 2 | Malignant Solid Tumor - Malignant Nervous System Neoplasm | - |
ILX651 | Phase 2 | Hormone-refractory Prostate Cancer | - |
XRP0038 (NV1FGF) | Phase 2 | Severe Peripheral Artery Occlusive Disease | - |
clofarabine (IV formulation) | Phase 2 | Acute Myelogenous Leukemia | - |
Interferon-β | Phase 2 | Multiple Sclerosis | - |
BIVV020 (SAR445088) | Phase 2 | Transplant Rejection | - |
CoV2 preS dTM-AF03 (low-dose) | Phase 2 | COVID-19 (Healthy Volunteers) | - |
Menomune®: A, C, Y, W 135 Meningococcal Polysaccharide | Phase 2 | Meningitis | - |
Acne mRNA vaccine | Phase 2 | Acne | - |
aminopterin | Phase 2 | Leukemia | - |
Teplizumab | Phase 2 | Type 1 Diabetes Mellitus | - |
Aldurazyme (Recombinant Human Alpha-L-Iduronidase) | Phase 2 | Mucopolysaccharidosis I | - |
Purified Vero Rabies Vaccine - Serum Free | Phase 2 | Rabies | - |
plerixafor | Phase 2 | Ewing's Sarcoma/Soft Tissue Sarcoma | - |
Avalglucosidase alfa (GZ402666) | Phase 2 | Glycogen Storage Disease Type II-Pompe's Disease | - |
RSV vaccine candiate formulation 1 | Phase 2 | Respiratory Syncytial Virus Immunization | - |
SAR110894 | Phase 2 | Dementia Alzheimer's Type | - |
Oxaliplatin, capecitabine, radiotherapy | Phase 2 | Rectal Neoplasms | - |
ZD6474 | Phase 2 | Carcinoma, Non-Small-Cell Lung | - |
Tetravalent CYD Dengue Vaccine , 5555 formulation | Phase 2 | Dengue Fever | - |
satavaptan (SR121463B) | Phase 2 | Ascites | - |
MenABCYW conjugate vaccine | Phase 2 | Meningococcal Immunisation | - |
S-1 | Phase 2 | Gastric Cancer | - |
Clostridium difficile toxoids A and B (Low-dose with adjuvant) | Phase 2 | Clostridium Difficile Infection | - |
Any Inhaled Corticosteroids as prescribed by treating physician as standard of care | Phase 2 | Chronic Obstructive Pulmonary Disease | - |
SAR445088 (BIVV020) | Phase 2 | Immune Thrombocytopenia (ITP) | - |
Quadrivalent Influenza mRNA Vaccine MRT5410 | Phase 2 | Influenza Immunization | - |
Influenza virus vaccine (2004-2005 Formulation) | Phase 2 | Influenza | - |
Split virion, inactivated Influenza vaccine | Phase 2 | Influenza | - |
Approvals, filings, and latest developments